F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivo

Por Winer, I., Wang, S., Lee, Y-E K., Fan, W., Gong, Y., Burgos-Ojeda, D., Spahlinger, G., Kopelman, R., Buckanovich, Ronald J.
Publicado em 2010